All
2 July 2020
CARB-X FUNDS ELIGO BIOSCIENCE TO DEVELOP CRISPR-BASED THERAPEUTICS DERIVED FROM BACTERIOPHAGES TO KILL SUPERBUGS AND PREVENT DEADLY INFECTIONS IN TRANSPLANT PATIENTS
(BOSTON) – CARB-X announced today that it is awarding up to US$1.82 million to Eligo Bioscience in Paris, France, with additional funding for a total award of up to US$7.05...
25 June 2020
Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline
ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today...
19 June 2020
Lecturio is Providing Free Learning Resources to Help Combat the COVID-19 Pandemic
Due to the growing COVID-19 pandemic, the need for qualified healthcare professionals is growing worldwide. The video learning provider Lecturio has created a COVID-19...
17 June 2020
MedinCell announces the great success of its capital increase and raises 15.6 M€
MedinCell (FR0004065605 - MEDCL), a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas (the...
3 June 2020
Saagie Raises $28 million to Revolutionize Data Project Deployment
The French startup aims to become the leader in DataOps by accelerating international development and doubling staff over the next two years
2 June 2020
Seventure Partners joins ViroVet in series B funding
ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that it has...
3 April 2020
Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum Disorder
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders,...
11 March 2020
MOVE’N SEE raises funds with Seventure Partners and its Sport & Performance Capital fund
World leader in automatic cameramen robots for individual athletes and scene, MOVE ‘N SEE has just achieved a fundraising to extend its offer to 200 sports. This offer now...
9 March 2020
Seventure Partners invests in Novobind, the Vancouver-headquartered animal health biologics business
NovoBind Livestock Therapeutics Inc. is pleased to announce the successful close of an oversubscribed Series A investment round with a wide range of strategic and financial...